Search
Please see below for a list of search results.
In 2010, the HTA developed a new licence fee structure which has been in operation since 1 April 2011. The new fee structure followed consultation with stakeholders and is based on the activities of licensing each sector. The fee structure is reviewed each year and fees for the following year...
The HTA was asked to share a letter written to the University of Bristol regarding a process taking place at the university in 2008, as part of a process to create an artificial trachea for transplant
The HTA has been asked to provide information on when a licence was granted to an establishment.
It is important to us to be able to contact our licensed establishments by email. We have noticed that a number of those we are trying to reach are not reading important messages from HTA accounts.
This may be due to an establishment’s IT department or Internet service provider (ISP)...
Download these standards as a PDF.
Consent standards
Download these standards as a printable PDF.
Download these standards as a PDF.
In certain circumstances, the Human Tissue Act 2004 makes provision for a Licence Holder or Designated Individual or Licence Applicant to make Representations against a proposed licensing decision and / or make an Appeal to the HTA about a licensing decision.
The HTA licenses a number of activities relating to human tissue. We are also responsible for carrying out inspections to ensure licence conditions are being met. These activities are laid out in the Human Tissue Act and associated Regulations.
The activities licensed by the HTA are:
There are licensing exemptions in the HT Act 2004 and further specific exemptions in the HT Act 2004 (Ethical Approval, Exceptions from Licensing and Supply of Information about Transplants) Regulations 2006. These regulations came into force on 1 September 2006.